Only Activated but Not Non-activated Presynaptic Alpha 2-autoreceptors Interfere with Neighbouring Presynaptic Receptor Mechanisms
Overview
Authors
Affiliations
Experiments were carried out in rabbit cerebrocortical slices in order to find out whether the attenuation by presynaptic alpha 2-autoreceptors of effects mediated by presynaptic opioid kappa- and adenosine A1-receptors requires activation of the alpha 2-receptors. The slices were preincubated with 3H-noradrenaline and then superfused with medium containing desipramine 1 mumol/l. They were stimulated electrically either with single pulses or with trains of 32 pulses at 1 Hz. The overflow of tritium elicited by a single pulse amounted to 0.21% of the tritium content of the tissue. It was Ca2+-dependent and tetrodotoxin-sensitive and not changed by rauwolscine 1 mumol/l or yohimbine 0.3 mumol/l. Ethylketocyclazocine (EK; 0.1-10 nmol/l) and R-(-)-N6-phenylisopropyladenosine (PIA; 1-1,000 nmol/l) potently inhibited the overflow evoked by a single pulse, and their effects were not changed by yohimbine. - The overflow of tritium elicited by trains of 32 pulses at 1 Hz amounted to 0.92% of the tritium content of the tissue and was increased approximately fourfold by yohimbine 0.3 mumol/l. EK and PIA were less potent inhibitors than in the one pulse experiments. Yohimbine greatly enhanced the effects of EK and PIA. The enhancement was even more pronounced when the Ca2+ concentration in the medium was reduced in order to obtain a control tritium overflow similar to that evoked by 32 pulses in the absence of yohimbine. The results demonstrate that there is no alpha 2-adrenergic autoinhibition when noradrenaline release is elicited by a single pulse. Under these conditions, the non-activated presynaptic alpha 2-adrenoceptor does not interfere with presynaptic opioid kappa- and adenosine A1-receptor mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)
Berger B, Rothmaier A, Wedekind F, Zentner J, Feuerstein T, Jackisch R Br J Pharmacol. 2006; 148(6):795-806.
PMID: 16751796 PMC: 1617080. DOI: 10.1038/sj.bjp.0706782.
Karunanithi S, Lavidis N Br J Pharmacol. 2001; 132(2):403-10.
PMID: 11159688 PMC: 1572583. DOI: 10.1038/sj.bjp.0703842.
Jackisch R, Hotz H, Allgaier C, Hertting G Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(3):250-8.
PMID: 8208303 DOI: 10.1007/BF00169291.
von Kugelgen I, Kurz K, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(2):125-32.
PMID: 7909584 DOI: 10.1007/BF00169828.
Mayer A, Limberger N, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(6):632-43.
PMID: 2907613 DOI: 10.1007/BF00165627.